Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Terashima

Showing results (171-180 of 225) with videos related to

Pageof 23
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1991
[Phase II study of 5'-DFUR in uterine cervical cancer and ovarian cancer]K Noda, M Ikeda, Y Saito, et al.
Nihon Gan Chiryo Gakkai Shi|July 20, 1990
[A clinical study of recombinant human G-CSF in gynecological tumor patients with neutropenia due to chemotherapy (rG.CSF Clinical Study Group)]Y Terashima, K Ochiai, M Hashimoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1992
[A study of preclinical and clinical usefulness of new tumor markers of ovarian carcinoma, CA 54/61 and CA 602. 1. Evaluation of the diagnostic accuracy of CA 54/61, a study of the normal range of its values and its correlation with other tumor markers]S Nozawa, Y Udagawa, H Sasaki, et al.
Kokyu to Junkan. Respiration & Circulation|November 1, 1990
[Role of systemic and pulmonary hemodynamics in genesis pleural effusion in congestive heart failure]S Ohshima, K Gotoh, Y Yagi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1992
[Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers]S Nozawa, Y Udagawa, H Sasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1994
[Studies on clinical usefulness of new tumor markers of ovarian cancer, CA54/61 and CA602--III. Measurement of serum samples from patients with various benign or malignant diseases]S Nozawa, Y Udagawa, H Sasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1988
[Phase II study of carboplatin in cervical carcinoma]K Noda, T Kato, M Ikeda, et al.
Asia-Oceania Journal of Obstetrics and Gynaecology|June 1, 1991
Risk determination in cases with an extra minute chromosome: prenatal diagnosisH Sago, K Iinuma, S Yoshiwara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1994
[Phase I clinical study of 21-consecutive-day oral administration of etoposide]K Noda, M Fukuoka, H Komatsu, et al.
European Journal of Pain (London, England)|October 23, 2015
Attenuation of pain behaviour by local administration of alpha-2 adrenoceptor antagonists to dorsal root ganglia in a rat radiculopathy modelI Ogon, T Takebayashi, T Miyakawa, et al.
Pageof 23

Showing results (171-180 of 225) with videos related to

Sort By:
Pageof 23
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1991
[Phase II study of 5'-DFUR in uterine cervical cancer and ovarian cancer]K Noda, M Ikeda, Y Saito, et al.
Nihon Gan Chiryo Gakkai Shi|July 20, 1990
[A clinical study of recombinant human G-CSF in gynecological tumor patients with neutropenia due to chemotherapy (rG.CSF Clinical Study Group)]Y Terashima, K Ochiai, M Hashimoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1992
[A study of preclinical and clinical usefulness of new tumor markers of ovarian carcinoma, CA 54/61 and CA 602. 1. Evaluation of the diagnostic accuracy of CA 54/61, a study of the normal range of its values and its correlation with other tumor markers]S Nozawa, Y Udagawa, H Sasaki, et al.
Kokyu to Junkan. Respiration & Circulation|November 1, 1990
[Role of systemic and pulmonary hemodynamics in genesis pleural effusion in congestive heart failure]S Ohshima, K Gotoh, Y Yagi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1992
[Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers]S Nozawa, Y Udagawa, H Sasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1994
[Studies on clinical usefulness of new tumor markers of ovarian cancer, CA54/61 and CA602--III. Measurement of serum samples from patients with various benign or malignant diseases]S Nozawa, Y Udagawa, H Sasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1988
[Phase II study of carboplatin in cervical carcinoma]K Noda, T Kato, M Ikeda, et al.
Asia-Oceania Journal of Obstetrics and Gynaecology|June 1, 1991
Risk determination in cases with an extra minute chromosome: prenatal diagnosisH Sago, K Iinuma, S Yoshiwara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1994
[Phase I clinical study of 21-consecutive-day oral administration of etoposide]K Noda, M Fukuoka, H Komatsu, et al.
European Journal of Pain (London, England)|October 23, 2015
Attenuation of pain behaviour by local administration of alpha-2 adrenoceptor antagonists to dorsal root ganglia in a rat radiculopathy modelI Ogon, T Takebayashi, T Miyakawa, et al.
Pageof 23